Status:
COMPLETED
A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs
Lead Sponsor:
Bayer
Conditions:
Coronary Artery Disease
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The study will focus on effectiveness and safety of rivaroxaban (Xarelto) when given together with acetylsalicylic acid (combination therapy) to patients suffering from coronary artery disease (a cond...
Eligibility Criteria
Inclusion
- Adult (≥18 years) patient (except Taiwan ≥ 20 years old).
- Diagnosis of CAD or symptomatic PAD.
- Treatment according to local marketing authorization, rivaroxaban 2.5 mg \[BID\] plus Acetylsalicylic acid (ASA) 75-100 mg \[OD\] started up to 4 weeks before or after the ICF is signed.
- Only in those countries with a marketing authorization of rivaroxaban in the Acute Coronary Syndrome (ACS) indication, patients already on rivaroxaban treatment for ACS for more than 4 weeks, who are subsequently fulfilling criteria for CAD, are also allowed to be enrolled.
Exclusion
- Contra-indications according to the local marketing authorization.
- Patients who will be treated with chronic anticoagulation therapy other than rivaroxaban 2.5 mg given for CAD/PAD.
- Participation in an interventional trial.
- Enrolment in the XATOA study.
Key Trial Info
Start Date :
May 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 29 2023
Estimated Enrollment :
3189 Patients enrolled
Trial Details
Trial ID
NCT04401761
Start Date
May 28 2020
End Date
September 29 2023
Last Update
October 25 2023
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations
Multiple Locations, Belgium
2
Many Locations
Multiple Locations, China
3
Many Locations
Multiple Locations, Colombia
4
Many Locations
Multiple Locations, Italy